Stocks
CRISPR Therapeutics AGCRSP
NASDAQHealthcareBiotechnology$48.75-0.25%
A biotechnology company focused on developing gene-editing therapies using CRISPR/Cas9 technology to treat serious genetic diseases. Its pipeline includes ex vivo and in vivo programs targeting conditions such as sickle cell disease, beta thalassemia, and oncology indications, with key collaboration...
Market Cap: $4.7B52W Range: $30.04 – $78.48
Congressional Interest in CRISPR Therapeutics AG (CRSP)
4 members of Congress have disclosed 8 trades in CRISPR Therapeutics AG (CRSP), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 4 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
8
Unique Politicians
4
Buys
4
Sells
4
Who in Congress Is Trading CRSP?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-06-01 | Michael Fq San Nicolas | buy | $1K – $15K |
| 2021-09-20 | Thomas Suozzi | sell | $50K – $100K |